Natera, Inc. logo

Natera, Inc.

NASDAQ:NTRA

Overview | Financials
Company Name Natera, Inc.
Symbol NTRA
Currency USD
Price 90.33
Market Cap 10,763,000,160
Dividend Yield 0%
52-week-range 36.9 - 98.82
Industry Diagnostics & Research
Sector Healthcare
CEO Mr. Steven Leonard Chapman
Website https://www.natera.com

An error occurred while fetching data.

About Natera, Inc.

Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify single-gene

Related Stocks

Merit Medical Systems, Inc. logo

Merit Medical Systems, Inc.

MMSI

71.51 USD

LivaNova PLC logo

LivaNova PLC

LIVN

51.87 USD

Surgery Partners, Inc. logo

Surgery Partners, Inc.

SGRY

24.47 USD

Arrowhead Pharmaceuticals, Inc. logo

Arrowhead Pharmaceuticals, Inc.

ARWR

22.53 USD

CureVac N.V. logo

CureVac N.V.

CVAC

2.57 USD

Novavax, Inc. logo

Novavax, Inc.

NVAX

3.89 USD

Blueprint Medicines Corporation logo

Blueprint Medicines Corporation

BPMC

88.38 USD

Cytokinetics, Incorporated logo

Cytokinetics, Incorporated

CYTK

67.93 USD

Financials

Numbers are in millions USD

Numbers are in millions USD